Tuesday, October 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Mergers & Acquisitions

Countdown to Acquisition: AvidXchange Nears Privatization Milestone

Dieter Jaworski by Dieter Jaworski
September 11, 2025
in Mergers & Acquisitions, Tech & Software, Trading & Momentum
0
AvidXchange Holdings Stock
0
SHARES
104
VIEWS
Share on FacebookShare on Twitter

Shares of AvidXchange Holdings are exhibiting notable volatility as the financial technology company approaches the final stages of its transition to private ownership. Trading activity continues to be dominated by the impending acquisition led by TPG in partnership with Corpay.

Technical Indicators Signal Downward Momentum

The stock is firmly entrenched in a downward trajectory. In the latest session, shares experienced a marginal decline of 0.101%, closing at $9.93 after trading at $9.94 previously. While the trading range remained narrow at 0.151% between the daily low and high, activity intensified with a volume of 2 million shares changing hands.

This bearish sentiment is reinforced by key technical indicators. A sell signal triggered from a pivot top point established on Tuesday initiated the recent pullback. Further confirming the weak momentum, the 3-month MACD is also flashing a sell recommendation. These technical warnings suggest persistent downward pressure is likely to continue until a new support level is established.

$2.2 Billion Acquisition Nears Finish Line

The overarching market driver remains the all-cash acquisition proposal from TPG and Corpay. The deal values AvidXchange at approximately $2.2 billion, offering shareholders $10.00 per share.

Key transaction details include:

Should investors sell immediately? Or is it worth buying AvidXchange Holdings?

  • Offer Price: $10.00 per share in cash
  • Total Enterprise Value: $2.2 billion
  • Acquisition Premium: 22% above the share price on May 6, 2025, and 45% above the March 12, 2025 level
  • Expected Completion: Fourth quarter of 2025

Through its private equity platform, TPG will secure majority control, while Corpay maintains a 33% stake with an option for full acquisition by 2028.

Shareholder Vote Represents Final Hurdle

A virtual special meeting scheduled for Tuesday, September 16, will see shareholders cast their votes on the acquisition proposal. This event represents the final significant step before the transaction can be formally completed.

Analyst Consensus Remains Cautious

Market experts maintain a reserved stance toward the stock. The consensus rating among 17 Wall Street analysts currently stands at “Reduce,” with recommendations consisting of:

  • 1 buy recommendation
  • 14 hold ratings
  • 2 sell recommendations

The average price target of $10.04 suggests minimal upside potential of just 0.96% from current levels—a realistic assessment given the fixed acquisition price.

Financial Guidance Suspended Pending Acquisition

Company management has suspended its financial outlook for fiscal year 2025 since presenting Q2 2025 results on August 6. This suspension represents a logical consequence of the pending acquisition, which now commands the market’s full attention.

Ad

AvidXchange Holdings Stock: Buy or Sell?! New AvidXchange Holdings Analysis from October 28 delivers the answer:

The latest AvidXchange Holdings figures speak for themselves: Urgent action needed for AvidXchange Holdings investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 28.

AvidXchange Holdings: Buy or sell? Read more here...

Tags: AvidXchange Holdings
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Centrus Energy Stock
Analysis

Centrus Energy Shares Signal Potential Market Reversal

October 28, 2025
Warner Bros. Discovery (A) Stock
Analysis

Acquisition Battle Intensifies for Warner Bros. Discovery

October 28, 2025
First Solar Stock
Analysis

First Solar Shares Continue Their Record-Breaking Ascent

October 28, 2025
Next Post
Zurn Water Solutions Stock

Zurn Water Solutions Stock Reaches Unprecedented Peak

Red Cat Stock

Red Cat Stock Plummets Despite Major Defense Sector Expansion

Micron Stock

Micron Emerges as a Critical Force in the AI Hardware Landscape

Recommended

Cricut Stock

Cricut’s Aggressive Discount Strategy Aims to Revive Slumping Sales

3 weeks ago
Red Cat Stock

Red Cat Stock Plummets Despite Major Defense Sector Expansion

2 months ago
Childrens Place Stock

Children’s Place Faces Pivotal Earnings Test Amid Strategic Overhaul

2 months ago
Robinhood Stock

Robinhood’s Strategic Expansion into Prediction Markets

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Biotech Firm aTyr Pharma Faces Investor Lawsuits Following Clinical Trial Setback

Amgen’s Pivotal Moment: Legal Win Sets Stage for Critical Earnings Report

Centrus Energy Shares Signal Potential Market Reversal

Acquisition Battle Intensifies for Warner Bros. Discovery

First Solar Shares Continue Their Record-Breaking Ascent

Tech Stocks Soar as Nasdaq 100 Reaches Unprecedented Peak

Trending

Texas Instruments Stock
Earnings

Texas Instruments Shares Tumble Following Disappointing Earnings Outlook

by Andreas Sommer
October 28, 2025
0

Texas Instruments, a major player in the semiconductor industry, is facing significant headwinds. The company's stock experienced...

Philip Morris Stock

Investor Skepticism Meets Strong Performance at Philip Morris

October 28, 2025
Sarepta Therapeutics Stock

Sarepta Therapeutics Faces Critical Earnings Test Amid Regulatory Uncertainty

October 28, 2025
aTyr Pharma Stock

Biotech Firm aTyr Pharma Faces Investor Lawsuits Following Clinical Trial Setback

October 28, 2025
Amgen Stock

Amgen’s Pivotal Moment: Legal Win Sets Stage for Critical Earnings Report

October 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Texas Instruments Shares Tumble Following Disappointing Earnings Outlook
  • Investor Skepticism Meets Strong Performance at Philip Morris
  • Sarepta Therapeutics Faces Critical Earnings Test Amid Regulatory Uncertainty

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com